Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages 249-252

  Saraceni, Valeria ^a   Pacheco, Antonio Guilherme ^b   Golub, Jonathan E ^c   Vellozo, Vitoria ^a   King, Bonnie S ^c   Cavalcante, Solange C ^a   Eldred, Lois ^c   Chaisson, Richard E ^c   Durovni, Betina ^a  

^a SMSDC   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS related opportunistic infections; Disease prevention; Guideline adherence; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; AGED; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CARE; PHYSICIAN ATTITUDE; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PROPHYLAXIS; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; VIRUS LOAD;

EID: 79959625107     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70184-2     Document Type: Article

References (23)

1. Jamal LF, Moherdaui F. Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control. Rev Saúde Pública 2007; 41 Suppl 1:104-10.
2. Pacheco AG, Durovni B, Cavalcante SC et al. AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS ONE 2008; 3:e31-2.
3. Saraceni V, King BS, Golub JE, Lauria LM, Cavalcante SC, Durovni B. Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro City, Brazil. Int J Tuberc Lung Dis 2008; 12:769-72.
4. Secretaria Municipal de Saúde do Rio de Janeiro. Gerência do Programa de DST/AIDS. Rio de Janeiro; 2008. Accessed from [http://www.saude.rio.rj.gov.br/aids/].
5. Brazil. Ministry of Health. Recommendations on Antiretroviral Therapy in HIV-infected Adults and Adolescents. Brasilia; 2008.
6. Brand C, Landgren F, Hutchinson A, Jones C, Macgregor L, Campbell D. Clinical practice guidelines: barriers to durability after effective early implementation. Intern Med J 2005; 35:162-9.
7. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282:1458-65.
8. Centers for Disease Control and Prevention (CDC). Current Trends Prevention of Acquired Immune Deficiency Syndrome (AIDS): Report of Inter-Agency Recommendations. MMWR 1983; 32:101-3.
9. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS 2004; 18(Suppl 3):S15-20.
10. Moulton L, Golub JE, Durovni B et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials 2007; 4:190-9.
11. Secretaria Municipal de Saúde do Rio de Janeiro. Gerência do Programa de Pneumologia Sanitária. Rio de Janeiro; 2008. Accessed from [http://www.saude.rio.rj.gov.br/tuberculose/].
12. Sackoff J, McFarland J, Su S, Bryan E. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:387-92.
13. Montaner JS, Phillips P, Zala C, Craib KJ, O'Shaughnessy MV, Schechter MT. Adherence to guidelines for the prevention of HIV-related respiratory diseases. Eur Respir J 1996; 9:2318-22.
14. Golub JE, Saraceni V, Cavalcante SC et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21:1441-8.
15. Sackoff JE, Torian LV, Frieden TR, Brudney KF, Menzies IB. Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS 1998; 12:2017-23.
16. Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. Int J Tuberc Lung Dis 2006; 10:209-14.
17. Antonucci G, Girardi E, Raviglione M et al. Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. Eur Respir J 2001; 18:369-75.
18. De Riemer K, Daley CL, Reingold AL. Preventing tuberculosis among HIV-infected patients: a survey of physicians' knowledge and practices. Prev Med 1999; 28:437-41.
19. Hiransuthikul N, Hiransuthikul P, Nelson KE, Jirawisit M, Paewplot R, Kasak S. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand. Southeast Asian J Trop Med Public Health 2005; 36:1208-15.
20. Vellozo V, Israel G, Saraceni V, Ferreira RCM, Durovni B, DeLuca A. THRio qualitative study (Abstract PS-82357-20). In: Program and abstracts: 38th Union World Conference on Lung Health Paris: France, 2008.
21. Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis 2007; 196 Suppl 1:S52-62.
22. Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992; 145:494-7.
23. WHO. WHO Three I's Meeting: Report of a Joint WHO HIV/AIDS and TB Department Meeting. Geneva, Switzerland: WHO, 2008.